209 related articles for article (PubMed ID: 10439113)
1. Structural analysis of the amyloidogenic kappa Bence Jones protein (FUR).
Odani S; Komori Y; Gejyo F
Amyloid; 1999 Jun; 6(2):77-88. PubMed ID: 10439113
[TBL] [Abstract][Full Text] [Related]
2. Amino acid sequence of an amyloidogenic Bence Jones protein in myeloma-associated systemic amyloidosis.
Tonoike H; Kametani F; Hoshi A; Shinoda T; Isobe T
FEBS Lett; 1985 Jun; 185(1):139-41. PubMed ID: 3922791
[TBL] [Abstract][Full Text] [Related]
3. Primary structure of the variable part of an amyloidogenic Bence-Jones Protein (Mev.). An unusual insertion in the third hypervariable region of a human kappa-immunoglobulin light chain.
Eulitz M; Linke RP
Hoppe Seylers Z Physiol Chem; 1982 Nov; 363(11):1347-58. PubMed ID: 6816713
[TBL] [Abstract][Full Text] [Related]
4. A glycosylated Bence Jones protein and its autologous amyloid light chain containing potentially amyloidogenic residues.
Foss GS; Nilsen R; Cornwell GC; Husby G; Sletten K
Scand J Immunol; 1998 Apr; 47(4):348-54. PubMed ID: 9600316
[TBL] [Abstract][Full Text] [Related]
5. Complete amino acid sequence determinations demonstrate identity of the urinary Bence Jones protein (BJP-DIA) and the amyloid fibril protein (AL-DIA) in a case of AL-amyloidosis.
Klafki HW; Kratzin HD; Pick AI; Eckart K; Karas M; Hilschmann N
Biochemistry; 1992 Mar; 31(12):3265-72. PubMed ID: 1554711
[TBL] [Abstract][Full Text] [Related]
6. Light chain cardiomyopathy. Structural analysis of the light chain tissue deposits.
Gallo G; Goñi F; Boctor F; Vidal R; Kumar A; Stevens FJ; Frangione B; Ghiso J
Am J Pathol; 1996 May; 148(5):1397-406. PubMed ID: 8623912
[TBL] [Abstract][Full Text] [Related]
7. Kinetic stability and sequence/structure studies of urine-derived Bence-Jones proteins from multiple myeloma and light chain amyloidosis patients.
Blancas-Mejía LM; Martin EB; Williams A; Wall JS; Ramirez-Alvarado M
Biophys Chem; 2017 Nov; 230():89-98. PubMed ID: 28916410
[TBL] [Abstract][Full Text] [Related]
8. Structural relationship of lambda-type light chains with AL amyloidosis.
Alim MA; Yamaki S; Hossain MS; Takeda K; Yamagata F; Takashi I; Shinoda T
Clin Immunol; 1999 Mar; 90(3):399-403. PubMed ID: 10075869
[TBL] [Abstract][Full Text] [Related]
9. Constant region of a kappa III immunoglobulin light chain as a major AL-amyloid protein.
Engvig JP; Olsen KE; Gislefoss RE; Sletten K; Wahlström O; Westermark P
Scand J Immunol; 1998 Jul; 48(1):92-8. PubMed ID: 9714416
[TBL] [Abstract][Full Text] [Related]
10. Structural relationship of kappa-type light chains with AL amyloidosis: multiple deletions found in a VkappaIV protein.
Alim MA; Yamaki S; Hossain MS; Takeda K; Kozima M; Izumi T; Takashi I; Shinoda T
Clin Exp Immunol; 1999 Dec; 118(3):344-8. PubMed ID: 10594550
[TBL] [Abstract][Full Text] [Related]
11. Nephrotoxic potential of Bence Jones proteins.
Solomon A; Weiss DT; Kattine AA
N Engl J Med; 1991 Jun; 324(26):1845-51. PubMed ID: 1904132
[TBL] [Abstract][Full Text] [Related]
12. Novel human light chain V kappa segment: serologic and structural analyses of the kappa III-like Bence Jones protein and IgG kappa light chain REE.
Prelli F; Tummolo D; Solomon A; Frangione B
J Immunol; 1986 Jun; 136(11):4169-73. PubMed ID: 2422275
[TBL] [Abstract][Full Text] [Related]
13. Recombinant immunoglobulin variable domains generated from synthetic genes provide a system for in vitro characterization of light-chain amyloid proteins.
Stevens PW; Raffen R; Hanson DK; Deng YL; Berrios-Hammond M; Westholm FA; Murphy C; Eulitz M; Wetzel R; Solomon A
Protein Sci; 1995 Mar; 4(3):421-32. PubMed ID: 7795526
[TBL] [Abstract][Full Text] [Related]
14. Primary structure of the variable region of an amyloidogenic Bence Jones protein NIG-77.
Tonoike H; Kametani F; Hoshi A; Shinoda T; Isobe T
Biochem Biophys Res Commun; 1985 Feb; 126(3):1228-34. PubMed ID: 3977913
[TBL] [Abstract][Full Text] [Related]
15. Bence Jones proteins and light chains of immunoglobulins. Preferential association of the V lambda VI subgroup of human light chains with amyloidosis AL (lambda).
Solomon A; Frangione B; Franklin EC
J Clin Invest; 1982 Aug; 70(2):453-60. PubMed ID: 6808027
[TBL] [Abstract][Full Text] [Related]
16. Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes.
Harris DL; King E; Ramsland PA; Edmundson AB
J Mol Recognit; 2000; 13(4):198-212. PubMed ID: 10931557
[TBL] [Abstract][Full Text] [Related]
17. Effect of lysine modification on the stability and cellular binding of human amyloidogenic light chains.
Davern S; Murphy CL; O'Neill H; Wall JS; Weiss DT; Solomon A
Biochim Biophys Acta; 2011 Jan; 1812(1):32-40. PubMed ID: 20692337
[TBL] [Abstract][Full Text] [Related]
18. Structural identity of Bence Jones and amyloid fibril proteins in a patient with plasma cell dyscrasia and amyloidosis.
Terry WD; Page DL; Kimura S; Isobe T; Osserman EF; Glenner GG
J Clin Invest; 1973 May; 52(5):1276-81. PubMed ID: 4700495
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin D myeloma and amyloidosis: immunochemical and structural studies of Bence Jones and amyloid fibrillar proteins.
White GC; Jacobson RJ; Binder RA; Linke RP; Glenner GG
Blood; 1975 Nov; 46(5):713-22. PubMed ID: 809071
[TBL] [Abstract][Full Text] [Related]
20. Primary structure of the variable region of a human lambda VI light chain: Bence Jones protein SUT.
Frangione B; Moloshok T; Solomon A
J Immunol; 1983 Nov; 131(5):2490-3. PubMed ID: 6415173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
